Data from intraductally transplanted orthotopic xenografts using patient-derived organoids also implicates KRAS amplification in promoting squamous-like, invasive features within heterogeneous tumours, since inducible genetic activation of KRAS promotes an invasive phenotype in these models [58]. The gene discussed is KRAS; the disease is neoplasm.